272 related articles for article (PubMed ID: 31091744)
1. Review: Targeting the Transforming Growth Factor-Beta Pathway in Ovarian Cancer.
Roane BM; Arend RC; Birrer MJ
Cancers (Basel); 2019 May; 11(5):. PubMed ID: 31091744
[TBL] [Abstract][Full Text] [Related]
2. Loss of c-myc repression coincides with ovarian cancer resistance to transforming growth factor beta growth arrest independent of transforming growth factor beta/Smad signaling.
Baldwin RL; Tran H; Karlan BY
Cancer Res; 2003 Mar; 63(6):1413-9. PubMed ID: 12649207
[TBL] [Abstract][Full Text] [Related]
3. Transforming growth factor-beta in cancer and metastasis.
Jakowlew SB
Cancer Metastasis Rev; 2006 Sep; 25(3):435-57. PubMed ID: 16951986
[TBL] [Abstract][Full Text] [Related]
4. TGF-beta signaling in cancer treatment.
Fabregat I; Fernando J; Mainez J; Sancho P
Curr Pharm Des; 2014; 20(17):2934-47. PubMed ID: 23944366
[TBL] [Abstract][Full Text] [Related]
5. The expression of vascular endothelial growth factor and transforming growth factor-beta associates with angiogenesis in epithelial ovarian cancer.
Nakanishi Y; Kodama J; Yoshinouchi M; Tokumo K; Kamimura S; Okuda H; Kudo T
Int J Gynecol Pathol; 1997 Jul; 16(3):256-62. PubMed ID: 9421092
[TBL] [Abstract][Full Text] [Related]
6. The activated transforming growth factor-beta signaling pathway in peritoneal metastases is a potential therapeutic target in ovarian cancer.
Yamamura S; Matsumura N; Mandai M; Huang Z; Oura T; Baba T; Hamanishi J; Yamaguchi K; Kang HS; Okamoto T; Abiko K; Mori S; Murphy SK; Konishi I
Int J Cancer; 2012 Jan; 130(1):20-8. PubMed ID: 21503873
[TBL] [Abstract][Full Text] [Related]
7. The role for transforming growth factor-beta (TGF-beta) in human cancer.
Gold LI
Crit Rev Oncog; 1999; 10(4):303-60. PubMed ID: 10654929
[TBL] [Abstract][Full Text] [Related]
8. Effects of 4-nonylphenol and bisphenol A on stimulation of cell growth via disruption of the transforming growth factor-β signaling pathway in ovarian cancer models.
Park MA; Choi KC
Chem Res Toxicol; 2014 Jan; 27(1):119-28. PubMed ID: 24308608
[TBL] [Abstract][Full Text] [Related]
9. Malignant cells, directors of the malignant process: role of transforming growth factor-beta.
Teicher BA
Cancer Metastasis Rev; 2001; 20(1-2):133-43. PubMed ID: 11831642
[TBL] [Abstract][Full Text] [Related]
10. TGF-β induces global changes in DNA methylation during the epithelial-to-mesenchymal transition in ovarian cancer cells.
Cardenas H; Vieth E; Lee J; Segar M; Liu Y; Nephew KP; Matei D
Epigenetics; 2014 Nov; 9(11):1461-72. PubMed ID: 25470663
[TBL] [Abstract][Full Text] [Related]
11. Platelets promote invasion and induce epithelial to mesenchymal transition in ovarian cancer cells by TGF-β signaling pathway.
Guo Y; Cui W; Pei Y; Xu D
Gynecol Oncol; 2019 Jun; 153(3):639-650. PubMed ID: 30928020
[TBL] [Abstract][Full Text] [Related]
12. Human epithelial-type ovarian tumour marker beta-2-microglobulin is regulated by the TGF-β signaling pathway.
Sun W; Gui L; Zuo X; Zhang L; Zhou D; Duan X; Ren W; Xu G
J Transl Med; 2016 Mar; 14():75. PubMed ID: 26983758
[TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor-beta and nitrates in epithelial ovarian cancer.
Khalifa A; Kassim SK; Ahmed MI; Fayed ST
Dis Markers; 1999 Dec; 15(4):249-58. PubMed ID: 10689548
[TBL] [Abstract][Full Text] [Related]
14. Role of dihydrotestosterone (DHT) on TGF-β1 signaling pathway in epithelial ovarian cancer cells.
Kohan-Ivani K; Gabler F; Selman A; Vega M; Romero C
J Cancer Res Clin Oncol; 2016 Jan; 142(1):47-58. PubMed ID: 26091707
[TBL] [Abstract][Full Text] [Related]
15. Long noncoding RNA H19 promotes transforming growth factor-β-induced epithelial-mesenchymal transition by acting as a competing endogenous RNA of miR-370-3p in ovarian cancer cells.
Li J; Huang Y; Deng X; Luo M; Wang X; Hu H; Liu C; Zhong M
Onco Targets Ther; 2018; 11():427-440. PubMed ID: 29403287
[TBL] [Abstract][Full Text] [Related]
16. Physical interaction of STAT1 isoforms with TGF-β receptors leads to functional crosstalk between two signaling pathways in epithelial ovarian cancer.
Tian X; Guan W; Zhang L; Sun W; Zhou D; Lin Q; Ren W; Nadeem L; Xu G
J Exp Clin Cancer Res; 2018 May; 37(1):103. PubMed ID: 29751820
[TBL] [Abstract][Full Text] [Related]
17. A Perspective on the Development of TGF-β Inhibitors for Cancer Treatment.
Huynh LK; Hipolito CJ; Ten Dijke P
Biomolecules; 2019 Nov; 9(11):. PubMed ID: 31744193
[TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor-beta: a target for cancer therapy.
Kelly RJ; Morris JC
J Immunotoxicol; 2010 Mar; 7(1):15-26. PubMed ID: 19916703
[TBL] [Abstract][Full Text] [Related]
19. Chinese medicine Bu-Fei decoction attenuates epithelial-mesenchymal transition of non-small cell lung cancer via inhibition of transforming growth factor β1 signaling pathway in vitro and in vivo.
He XR; Han SY; Li XH; Zheng WX; Pang LN; Jiang ST; Li PP
J Ethnopharmacol; 2017 May; 204():45-57. PubMed ID: 28412214
[TBL] [Abstract][Full Text] [Related]
20. Transforming growth factor-β signaling: Tumorigenesis and targeting for cancer therapy.
Ahmadi A; Najafi M; Farhood B; Mortezaee K
J Cell Physiol; 2019 Aug; 234(8):12173-12187. PubMed ID: 30537043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
